ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

181
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
bullishESR Group
10 Jun 2019 06:45

Last Week in GER Research: ESR Cayman, Hansoh Pharma, China East Education and Tencent

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the valuation for...

Logo
704 Views
Share
bullishESR Group
08 Jun 2019 12:16

ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
03 Jun 2019 04:21

Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs

Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...

Logo
726 Views
Share
bullishESR Group
01 Jun 2019 11:47

ECM Weekly (1 Jun 2019) - Hansoh, China East Edu, GSX, CSSC (HK) Shipping, China Tobacco

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
30 May 2019 16:38

Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End

Hansoh Pharma, the largest pharmaceutical listing in Hong Kong this year, launched its book building today. In our previous insights (links...

Logo
864 Views
Share
x